• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Submit for the Fierce AI Innovation Awards, Entries close at midnight
Daiichi
Biotech

How Daiichi Sankyo plans to stay ahead in the ADC game

For Daiichi and its new head of R&D, the challenge is about outrunning the very ADC gold rush the company helped ignite.
Angus Liu Jun 17, 2026 6:00pm
field plow tractor wheat farm dust row plant grow

cAMPfield harvests $180M series A to advance oral IBD asset

Jun 18, 2026 10:34am
How NECs AI and oral delivery system are redefining personalized cancer therapy

How NEC's AI and oral delivery system are redefining personalized cancer therapy

Brought to you by NEC Bio
pills oral bottle medicine therapy drug

Nortiva purrs into action with long-acting Lynx platform

Jun 18, 2026 8:00am
IPO initial public offering

Kardigan buttons up $400M upsized IPO for phase 3 push

Jun 18, 2026 7:28am
A graphic symbolizing one group acquiring another

Biogen inks $1B RayThera buyout to bag immunology assets

Jun 18, 2026 4:10am
More News

F2G, Shionogi prep regulatory push after antifungal passes ph. 3

Jun 18, 2026 12:01am

Vedana surfaces with $46M to develop migraine prevention therapies

Jun 17, 2026 9:48am

Fierce Biotech Fundraising Tracker '26: Triveni Bio & more

Jun 17, 2026 9:30am

UniQure stock surges after FDA U-turn clears path to filing

Jun 17, 2026 9:10am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings